Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.


Strengths

● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.

● The company's profit outlook over the next few years is a strong asset.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 64.59 times its estimated earnings per share for the ongoing year.

● Based on current prices, the company has particularly high valuation levels.

● In relation to the value of its tangible assets, the company's valuation appears relatively high.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.